Preventive Cardiovascular Pharmacotherapy Update 2022: A Case-Based Approach

Course overview

At the conclusion of this program, the participant will be able to 1. Review medications and lifestyle modifications that are recommended for the treatment and prevention of cardiovascular disease . 2. Explain recommendations from the American College of Cardiology_ American Heart Association guidelines for treatment of patients with hypertension, hypercholesterolemia, heart failure with reduced ejection fraction, peripheral arterial disease and atrial fibrillation. 3. Formulate a care plan for patients with resistant hypertension based on the 2018 American Heart Association scientific statement. 4. Describe the evidence supporting bedtime dosing of antihypertensive medications. 5. Apply the treatment approaches recommended in the 2018 ACC-AHA cholesterol guideline to patients with hypercholesterolemia. 6. Define the evidence and role in therapy of nonstatin medications in the treatment of hypercholesterolemia. 7. Examine results from cardiovascular outcome trials evaluating the use of angiotensin_neprilysin inhibition in heart failure with reduce ejection fraction. 8. Compare and contrast the evidence and guideline recommendations supporting the use of antiplatelet therapy for primary and secondary prevention patients. 9. Examine the evidence-based CV risk reduction benefits of medications used to treat type 2 diabetes. 10. Create treatment plans that reduce the risk of cardiovascular disease.